Healthcare

Interview | John Strapp, The Kinetix Group

Interview | John Strapp, The Kinetix Group

By

Key account managers for pharma brands can call on a major healthcare system and simultaneously change behavior in 1,000 HCPs. So it's really a B2B sell, explains The Kinetix Group's John Strapp.

POC community makes good on promises of transparency and accountability

POC community makes good on promises of transparency and accountability

By

After a scandal with one of point of care's biggest players, we examine how the community is living up to its promise of greater transparency.

Focus turns to future after Right to Try Act passes

Focus turns to future after Right to Try Act passes

Congress has finally passed the Right to Try Act, but does it go far enough?

Acquisition fever in July: What does it mean for agencies?

Acquisition fever in July: What does it mean for agencies?

By

Health agencies are in acquisition mode, with networks snapping up independents, and the M&A market looks poised to stay hot.

Study: Healthcare isn't as consumer centric as it wants to be

Study: Healthcare isn't as consumer centric as it wants to be

By

Prophet surveyed 240 healthcare organizations to find out where the industry is actually at on its shift to consumer centricity.

The 2018 MM&M Awards: The Shortlist

The 2018 MM&M Awards: The Shortlist

Find out who made award-winning work this year.

MedStar Health selects Doner as AOR

MedStar Health selects Doner as AOR

By

Doner will lead a branding effort for the health system that will roll out in 2019.

Pfizer reorg came on heels of its walk-back on price hikes

Pfizer reorg came on heels of its walk-back on price hikes

Wednesday's reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.

Interview | Sonja Foster-Storch & Michael Austin, GSW

Interview | Sonja Foster-Storch & Michael Austin, GSW

Ad agency GSW and parent company Syneos Health are all about healthcare. A conversation with GSW's Sonja Foster-Storch, president, North America, and Michael Austin, managing director, creative and technology, on why that's important.

2018 Agency 100 preview: a complete guide to a year of disruption

2018 Agency 100 preview: a complete guide to a year of disruption

By

This year's version of the Agency 100 aims to give you the most complete guide to disruptions in the environment in which agencies operate, ranging from fresh data privacy and security worries, to newer kinds of innovation and enterprise technology work.

Live, from Cannes: Interview | Angela Radcliffe, PulsePoint & Mark Evans, Langland

Live, from Cannes: Interview | Angela Radcliffe, PulsePoint & Mark Evans, Langland

How can consumer marketing behavior be integrated into the clinical trial space? At Cannes, Angela Radcliffe, GM of clinical trial solutions at PulsePoint, and Mark Evans, innovation director at Langland, discuss why it's imperative to change how clinical trials are marketed.

Interview | Kerry Murphy, Synapse

Interview | Kerry Murphy, Synapse

Synapse executive vice president Kerry Murphy explains the struggles and triumphs of the real-world applications of data analytics.

Inside pharma's trust problem

Inside pharma's trust problem

By

Public trust in the pharma industry has taken a dip, according to recent data. Do actual patients agree?

Fostering a diverse, inclusive work environment for LGBTQ talent

Fostering a diverse, inclusive work environment for LGBTQ talent

According to a 2014 study conducted by The Human Rights Campaign, the largest LGBTQ civil rights advocacy group in the U.S., 53% of all LGBTQ workers nationwide "hide who they are in the workplace."

Who's your prescriber now? Demand for NPs and PAs is booming, according to report

Who's your prescriber now? Demand for NPs and PAs is booming, according to report

Recent healthcare trends, including a physician shortage and the rise of value-based care centers, have put NPs and PAs on the fast track to recruiter popularity. Marketers, take note.

Confusion expected in wake of 'Right to Try' bill's signing

Confusion expected in wake of 'Right to Try' bill's signing

It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.

Comms outreach efforts pass the test for Interpace

Comms outreach efforts pass the test for Interpace

A combination of traditional and modern comms tactics help molecular diagnostic testing company Interpace craft messages that resonate with all key audiences.

How women can empower themselves to close biopharma's gender pay gap

How women can empower themselves to close biopharma's gender pay gap

By

Women healthcare leaders discussed the gender pay gap and tools for women to advocate for themselves on stage at MM&M's Hall of Femme event Thursday.

AARP, tech firms to test voice-based health tools among senior set

AARP, tech firms to test voice-based health tools among senior set

By

Pillo's voice-activated robot will be studied among those 50-plus with diabetes. The robot uses facial recognition and can respond HIPAA-compliantly to questions.

A tale of two headlines leads to breast cancer confusion

A tale of two headlines leads to breast cancer confusion

Healthcare journalists and communicators have an obligation to facilitate informed conversation, not simply put out information. Does the Times' take on a recent gene test live up to that standard?

We asked for your take on pharma's diversity push. Here are the responses

We asked for your take on pharma's diversity push. Here are the responses

MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.

Five things for pharma marketers to know: Monday, June 4, 2018

Five things for pharma marketers to know: Monday, June 4, 2018

By

New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior

Transparency may have taken a back seat on this diversity drive

Transparency may have taken a back seat on this diversity drive

By

MM&M/Publicis Health's first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn't feel like opening up about their diversity numbers.

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

AstraZeneca reprimanded by UK drug regulator for 'misleading' press release

By

A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.

Marijuana: a green grey zone for patients, doctors, and pharma companies

Marijuana: a green grey zone for patients, doctors, and pharma companies

By

Legalization of the drug for medical use is already having an impact on prescription patterns. But for patients and doctors alike, there are a lot of unanswered questions.

How drugmakers are facing the entrance of consumer giants into healthcare

How drugmakers are facing the entrance of consumer giants into healthcare

By

As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.

MM&M Hall of Femme 2018: The profiles

MM&M Hall of Femme 2018: The profiles

MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.

Alisa Lask, Galderma

Alisa Lask, Galderma

Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.

Neera Chaudhary, Golin

Neera Chaudhary, Golin

Neera Chaudhary is global president of healthcare of Golin.

Wendy Blackburn, Intouch Solutions

Wendy Blackburn, Intouch Solutions

Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.